Credit Suisse Group AG (NYSE: CS) has enlarged the banking syndicate underwriting the rights issue and announced the reference price for the proposed CHF4 billion capital raise.
Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S.
In the past month with the Russell 2000 index up roughly 7%, as compared to the S&P 500 index up nearly 4.8%, it is evident that small cap stocks are leading the charge in this bear market rally. The WisdomTree U.S.
Cryptocurrency exchange Blockchain.com is in the midst of a down-round fundraising campaign, which may result in a valuation reduction of more than 70%.
PTC Therapeutics Inc (NASDAQ:PTCT) entered into a strategic financing collaboration with Blackstone Inc (NYSE:BX). As part of the collaboration, Blackstone Life Sciences and…
Litigation with Sabby and Another Institutional Shareholder Settled
Kiromic BioPharma, Inc. (NASDAQ:KRBP) ("Kiromic" or the "Company"), a clinical-stage fully-integrated biotherapeutics company
Better Choice Company Inc. (NYSE:BTTR) (the "Company" or "Better Choice"), a pet health and wellness company, today announced that it has successfully extended and upsized the Company's existing